Seizures
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
2152
|
553
|
0.300 |
None |
1.000 |
2 |
|
1998 |
2004 |
Obesity
|
disease |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
2821
|
1111
|
0.020 |
None |
1.000 |
2 |
|
2013 |
2013 |
Generalized Absence Seizures
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
102
|
|
0.300 |
None |
1.000 |
2 |
|
1998 |
2004 |
Jacksonian Seizure
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
102
|
|
0.300 |
None |
1.000 |
2 |
|
1998 |
2004 |
Anxiety Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
840
|
163
|
0.300 |
None |
1.000 |
2 |
1
|
2009 |
2018 |
Cognition Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
607
|
47
|
0.020 |
None |
1.000 |
2 |
1
|
2014 |
2019 |
Alcohol Use Disorder
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
218
|
54
|
0.310 |
None |
1.000 |
2 |
|
2009 |
2013 |
Forced expiratory volume function
|
phenotype |
|
Organ or Tissue Function
|
272
|
1169
|
0.100 |
None |
1.000 |
1 |
25
|
2015 |
2015 |
Child Development Disorders, Pervasive
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
168
|
379
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Drug abuse
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
405
|
39
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Drug Use Disorders
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
121
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Psychotic symptom
|
phenotype |
|
Sign or Symptom
|
86
|
21
|
0.010 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Mental Depression
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1478
|
271
|
0.010 |
None |
< 0.001 |
1 |
|
2018 |
2018 |
Drug habituation
|
phenotype |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
196
|
19
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Depressive disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1719
|
297
|
0.010 |
None |
< 0.001 |
1 |
|
2018 |
2018 |
Cannabis Abuse
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
19
|
8
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Paranoia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
35
|
5
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Early onset schizophrenia
|
disease |
|
Mental or Behavioral Dysfunction
|
15
|
3
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Prescription Drug Abuse
|
phenotype |
Chemically-Induced Disorders; Mental Disorders
|
Finding
|
115
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Asthma
|
disease |
Respiratory Tract Diseases; Immune System Diseases
|
Disease or Syndrome
|
2096
|
1536
|
0.010 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Head and Neck Carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
786
|
118
|
0.010 |
None |
< 0.001 |
1 |
1
|
2019 |
2019 |
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
17
|
8
|
0.010 |
None |
< 0.001 |
1 |
|
2000 |
2000 |
response to bronchodilator
|
phenotype |
|
Organism Function
|
131
|
1106
|
0.100 |
None |
1.000 |
1 |
23
|
2015 |
2015 |
Atherosclerosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
2044
|
281
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Nasopharyngeal carcinoma
|
disease |
Neoplasms; Stomatognathic Diseases; Otorhinolaryngologic Diseases
|
Neoplastic Process
|
1553
|
320
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |